- Release Date: 24/04/20 10:03
- Summary: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
- Price Sensitive: Yes
- Download Document 144.87KB
-
- There are more pages in this discussion • 788 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
0.090(5.29%) |
Mkt cap ! $2.287B | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.81 | $1.72 | $8.254M | 4.665M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5313 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 12938 | 4 |
View Market Depth
| Last trade - 16.10pm 25/04/2025 (20 minute delay) ? |
| MSB (ASX) Chart |